Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study.
Rosa SlootAlexander BreskinLisandro D ColantonioAndrew G AllmonYing YuSwati SakhujaLigong ChenPaul MuntnerM Alan BrookhartNafeesa N DhalwaniPublished in: Epidemiology (Cambridge, Mass.) (2024)
A comparative effectiveness study of these treatments using the current approach would likely bias results due to the low number of PCSK9 mAb initiators.